2:conventional chemotherapy

3 trials

Sponsors

Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital), Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Institute of Hematology Blood Disease Hospital, Chinese Academy of Medical Sciences Peking Union Medical College

Conditions

lymphoplasmacytic lymphoma / Waldenstrom macroglobulinemianon-squamous non-small cell lung cancerpancreatic cancer

Phase 3

The comparison of autologous stem cell transplantation vs. conventional chemotherapy in newly diagnosed high risk lymphoplasmacytic lymphoma / Waldenstrom macroglobulinemia

RecruitingChiCTR-OIN-16008401

Institute of Hematology Blood Disease Hospital, Chinese Academy of Medical Sciences Peking Union Medical Collegelymphoplasmacytic lymphoma / Waldenstrom macroglobulinemia

Start: 2016-05-01Updated: 2017-04-18

Phase 4

Zilongjin tablets as an adjunct therapy to conventional chemotherapy in patients with non-squamous non-small cell lung cancer: a randomized and controlled clinical trial

RecruitingChiCTR-IIR-15007683

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicinenon-squamous non-small cell lung cancer

Start: 2016-01-01Updated: 2017-04-18

Clinical research of novel immunotherapy with PD-1 monoclonal antibody combined with activation of IFN signaling pathway in patients with pancreatic cancer

RecruitingChiCTR1800017665

Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital)pancreatic cancer

Start: 2018-11-01Updated: 2018-08-20